BONO, FRANCESCO GIUSEPPE
 Distribuzione geografica
Continente #
AS - Asia 157
NA - Nord America 141
EU - Europa 137
SA - Sud America 19
AF - Africa 4
Totale 458
Nazione #
US - Stati Uniti d'America 136
SG - Singapore 78
IT - Italia 48
DE - Germania 34
IN - India 28
CN - Cina 26
FI - Finlandia 19
BR - Brasile 17
SE - Svezia 8
JP - Giappone 7
EE - Estonia 6
BD - Bangladesh 5
CA - Canada 5
FR - Francia 4
GB - Regno Unito 4
HK - Hong Kong 4
IE - Irlanda 4
AT - Austria 3
VN - Vietnam 3
ZA - Sudafrica 3
AR - Argentina 2
CZ - Repubblica Ceca 2
PL - Polonia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
DZ - Algeria 1
ES - Italia 1
IQ - Iraq 1
LT - Lituania 1
NL - Olanda 1
PS - Palestinian Territory 1
TR - Turchia 1
Totale 458
Città #
Singapore 57
Munich 29
Santa Clara 22
Los Angeles 19
Bengaluru 18
Hefei 17
Dallas 16
Turku 16
Milan 14
Ashburn 7
Tokyo 7
Lawrence 5
Montreal 5
Princeton 5
Dublin 4
Hong Kong 4
Tremestieri Etneo 4
Adelfia 3
Asti 3
Boardman 3
Chandler 3
Helsinki 3
Johannesburg 3
London 3
New Delhi 3
San Francisco 3
São Paulo 3
Assago 2
Borgia 2
Boston 2
Brooklyn 2
Buffalo 2
Casoria 2
Chennai 2
Curitiba 2
Des Moines 2
Ginosa 2
Ho Chi Minh City 2
Nuremberg 2
Olomouc 2
Palo del Colle 2
Phoenix 2
Reggio Calabria 2
Rome 2
Shenzhen 2
Stockholm 2
Tashkent 2
Turin 2
Warsaw 2
Xian 2
Amsterdam 1
Ankara 1
Baghdad 1
Barbacena 1
Barretos 1
Bhanga 1
Bismarck 1
Bordj el Kiffan 1
Brasília 1
Buenos Aires 1
Chicago 1
Clearwater 1
Criciúma 1
Denver 1
Duque de Caxias 1
Guarulhos 1
Jalandhar 1
Jinan 1
Jinhua 1
Keswick 1
Mumbai 1
Narsingdi 1
New York 1
Norwalk 1
Ourinhos 1
Paraíba do Sul 1
Paris 1
Patna 1
Prineville 1
Ramallah 1
Recife 1
San Jose 1
San Miguel de Tucumán 1
Sanford 1
Santa Luzia 1
Santo André 1
Somma Vesuviana 1
Southbury 1
Suzano 1
The Dalles 1
Topeka 1
Vienna 1
Wilmington 1
Yên Bái 1
Totale 369
Nome #
Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 54
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 40
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 38
Regional Targeted Subcutaneous Injection of Botulinum Neurotoxin Type A in Refractory Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study 35
Neurological manifestations in patients and disease carriers in an Italian family with osteosclerosis 35
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of “organic” neurology 32
Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site 26
Periventricular white matter changes in idiopathic intracranial hypertension 25
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 24
Brainstem changes causing reversible RBD in patients with spontaneous intracranial hypotension: a longitudinal neuroimaging study 24
Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study 23
Parkinsonism during treatment with sodium valproate: A case report 23
An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease? 21
Effects of alcohol on ocular motor abnormalities in Ramsay-Hunt syndrome 21
HEADWORK Questionnaire: Why Do We Need a New Tool to Assess Work-Related Disability in Patients With Migraine? 20
Correction to: A video of best practice recommendations for making botulinum toxin therapy safe during the COVID?19 pandemic (Neurological Sciences, (2021), 42, 9, (3937-3938), 10.1007/s10072-021-05375-z) 19
Effect of mannitol bolus administration on cerebrospinal fluid pressure in patients with idiopathic intracranial hypertension: a pilot study 16
Mannitol effectiveness in lowering intracranial pressure in idiopathic intracranial hypertension: A case series 15
Totale 491
Categoria #
all - tutte 5.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 3 4 0 1 0 0 3 0 0
2021/202216 0 1 0 3 4 0 0 3 1 1 3 0
2022/202321 10 0 3 0 0 0 4 1 1 2 0 0
2023/202439 4 11 5 2 4 3 0 0 5 0 2 3
2024/2025266 38 16 8 3 12 37 6 7 31 9 42 57
2025/2026138 38 51 27 22 0 0 0 0 0 0 0 0
Totale 491